Stockscreener 앱 받기
49.92
1.46%
0.72
전일 마감가:
$49.20
열려 있는:
$49.48
하루 거래량:
580.63K
Relative Volume:
1.09
시가총액:
$2.36B
수익:
$1.10B
순이익/손실:
$186.50M
주가수익비율:
13.20
EPS:
3.7817
순현금흐름:
$267.19M
1주 성능:
+3.50%
1개월 성능:
+6.53%
6개월 성능:
-12.50%
1년 성능:
-19.24%
1일 변동 폭
$49.28
$50.27
1주일 범위
$47.80
$50.84
52주 변동 폭
$42.62
$71.07
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
명칭
Prestige Consumer Healthcare Inc
전화
(914) 524-6800
주소
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
49.92 | 2.36B | 1.10B | 186.50M | 267.19M | 3.7817 |
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-05-14 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-09-24 | 업그레이드 | Sidoti | Neutral → Buy |
| 2024-12-09 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2024-06-21 | 업그레이드 | DA Davidson | Neutral → Buy |
| 2022-11-17 | 개시 | Canaccord Genuity | Buy |
| 2022-05-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-05-09 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-08-07 | 다운그레이드 | DA Davidson | Buy → Neutral |
| 2020-06-29 | 업그레이드 | Sidoti | Neutral → Buy |
| 2020-04-14 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-04-07 | 재개 | Sidoti | Neutral |
| 2020-03-26 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-03-24 | 개시 | Oppenheimer | Perform |
| 2020-03-19 | 업그레이드 | DA Davidson | Neutral → Buy |
| 2019-01-15 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2017-12-04 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2017-06-02 | 업그레이드 | Jefferies | Underperform → Hold |
| 2017-05-22 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2016-12-27 | 재확인 | B. Riley & Co. | Buy |
| 2016-11-17 | 개시 | Gabelli & Co | Buy |
| 2016-08-12 | 업그레이드 | Sidoti | Neutral → Buy |
| 2016-03-08 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2016-02-05 | 개시 | Piper Jaffray | Overweight |
| 2015-11-30 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2014-04-28 | 재확인 | B. Riley & Co. | Buy |
| 2014-04-28 | 재확인 | Oppenheimer | Outperform |
| 2013-07-09 | 개시 | B. Riley & Co. | Buy |
모두보기
Prestige Consumer Healthcare Inc 주식(PBH)의 최신 뉴스
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now? - Zacks Investment Research
Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results - Yahoo Finance
How InvestingPro spotted Prestige Healthcare’s 43% stock decline By Investing.com - Investing.com
Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis $PBH - MarketBeat
What Does the Guidance Raise Mean for Prestige Consumer (NYSE:PBH)? - Kalkine Media
Prestige Consumer Healthcare stock falls 11% on Q4 revenue decline - scanx.trade
Prestige Consumer Q1FY27 Results: Revenue rises 6.5% to $266 million - scanx.trade
Transcript: Prestige Consumer Q1 2027 Earnings Conference Call - Benzinga
Prestige Consumer Latest Results: Sales guidance rises to $1.29B-$1.315B - scanx.trade
Prestige Consumer Healthcare acquires Breathe Right for $1.045bn - scanx.trade
Prestige prices $400 million 6.25% notes due 2034 - scanx.trade
Best Value Stocks to Buy for October 1st - Zacks Investment Research
PBH vs. NEOG: Which Stock Is the Better Value Option? - Zacks Investment Research
More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds – Company AnnouncementFT.com - Financial Times
More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds – Company AnnouncementFT.com - Financial Times
Has Prestige Consumer Healthcare (PBH) Fallen Far Enough On Earnings? - Yahoo Finance
Prestige Consumer Healthcare (PBH) Could Be 30% Undervalued After Its 2027 Targets - Yahoo Finance
Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow - Yahoo Finance
Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow - TradingView
Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow - TradingView
Prestige Consumer Healthcare at small-cap virtual conference: growth plan intact - Investing.com India
Prestige Consumer Healthcare at small-cap virtual conference: growth plan intact - Investing.com
A Look at Prestige Consumer Healthcare Inc (PBH) After 3.8% Decl - GuruFocus
Prestige Consumer Healthcare Inc. (PBH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Prestige Consumer Healthcare stock gains ahead of Sidoti event - AD HOC NEWS
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: 50% Upside Potential Amid Steady Revenue Growth - DirectorsTalk Interviews
Prestige Consumer Healthcare Inc (PBH) Shares Fall 3.2% -- What GF Score of 65 Tells Investors - GuruFocus
PBH: Portfolio expansion and brand integration drive growth, with Clear Eyes recovery a key focus - TradingView
Prestige Consumer Healthcare at Barclays conference: growth via niche brands - Investing.com Canada
Prestige Consumer Healthcare at Barclays conference: growth via niche brands - investing.com
Prestige Consumer Healthcare at Barclays conference: growth via niche brands - Investing.com India
How InvestingPro Fair Value spotted Prestige Healthcare’s 43% drop By Investing.com - Investing.com India
How InvestingPro Fair Value spotted Prestige Healthcare’s 43% drop By Investing.com - Investing.com
Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference - manilatimes.net
Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference - Yahoo! Finance Canada
Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference - Moomoo
Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference - Yahoo Finance
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Assessing a Promising 29.74% Potential Upside - DirectorsTalk Interviews
Is This the Right Time to Add PBH Stock to Your Portfolio? - TradingView
Is This the Right Time to Add PBH Stock to Your Portfolio? - Yahoo Finance
Precision Trading with Prestige Consumer Healthcare Inc. (PBH) Risk Zones - Stock Traders Daily
Prestige Consumer Healthcare stock holds steady as investors watch valuation and growth - AD HOC NEWS
Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek® Football Stress Test - Financial Times
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring A 29% Upside Potential - DirectorsTalk Interviews
PBH vs. SYK: Which Stock Is the Better Value Option? - Yahoo Finance
Prestige Consumer Healthcare Inc. (PBH) Investor Outlook: Exploring a 32% Upside Potential - DirectorsTalk Interviews
Nearly 40,000 Bottles of Eye Drops Recalled Nationwide - Yahoo
40,000 eye drop bottles recalled over potential contamination - Oman Observer
Nearly 40,000 eye drop bottles are recalled over potential contamination - The Seattle Times
40,000 bottles of eye drops across the US recalled over issues with sterility of product - inkl
Prestige Consumer Healthcare Inc (PBH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Prestige Consumer Healthcare Inc 주식 (PBH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Zerillo Jeffrey | Officer |
May 11 '26 |
Proposed Sale |
52.28 |
351 |
18,350 |
0 |
| Zerillo Jeffrey | Officer |
May 07 '26 |
Proposed Sale |
54.36 |
305 |
16,580 |
0 |
| Zerillo Jeffrey | Senior VP Operations |
May 07 '26 |
Sale |
54.36 |
305 |
16,580 |
42,161 |
| Zerillo Jeffrey | Officer |
May 06 '26 |
Proposed Sale |
54.99 |
1,207 |
66,374 |
0 |
| Zerillo Jeffrey | Officer |
May 05 '26 |
Proposed Sale |
55.32 |
346 |
19,141 |
0 |
| Zerillo Jeffrey | Senior VP Operations |
May 05 '26 |
Sale |
55.32 |
346 |
19,141 |
44,334 |
| Zerillo Jeffrey | Senior VP Operations |
May 05 '26 |
Sale |
54.99 |
1,207 |
66,373 |
42,820 |
| Zerillo Jeffrey | Senior VP Operations |
Feb 11 '26 |
Sale |
65.93 |
1,000 |
65,930 |
41,048 |
| Zerillo Jeffrey | Officer |
Feb 11 '26 |
Proposed Sale |
65.93 |
1,000 |
65,930 |
0 |
| Zerillo Jeffrey | Senior VP Operations |
Dec 01 '25 |
Sale |
60.00 |
281 |
16,860 |
42,048 |
0.16%
0.91%
자본화:
|
볼륨(24시간):